← Back to headlines
Teva Gains Approval for Biosimilar of Amgen's Prolia
Teva Pharmaceutical Industries has received approval for its biosimilar version of Amgen's osteoporosis drug, Prolia.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
